An LED-based intraoral device for photobiomodulation therapy was safe and reduced severe oral mucositis in patients with head ...
Leaders in oncology nursing and advanced practice spotlight the essential role of advanced practice providers in oncology.
BC, AOCNP, explains how ctDNA can inform prognosis, monitor disease progression, and guide treatment decisions in oncology.
Caleb Raine, PA-C explains what BCMA is and why it is a common bispecific antibody target in multiple myeloma.
The NCCN has added revumenib (Revuforj) to its guidelines for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) harboring NPM1 mutations, accordin ...
Pediatric oncology is defined not only by advanced treatments but also by the depth of support provided to patients and families, according to Scott C. Borinstein, MD, PhD, medical director of ...
Subcutaneous pembrolizumab has been approved across all indications, cutting chair and administration times with a median ...
C, OCN, discusses how patient comorbidities and adverse effect profiles guide CDK4/6 inhibitor choice in the first-line setting.
In an interview with Oncology Nursing News, Kirschner, who serves as the director of program development at the Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback